It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

Natural capital went mainstream in 2024, with biodiversity bonds hitting new highs and record shareholder resolutions on ...

GSK’s NgG shot is based on generalised modules ... Germany, Spain, Brazil, the Philippines, and South Africa, with a readout expected in 2025. Meanwhile, some research has found that vaccines ...

GSK Plc’s Chief Executive Officer Emma Walmsley is looking to do more deals as the British drugmaker doubles down on its ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Many of its people are fierce and violent, given to pillaging and banditry. From trade winds to porcelain vessels, all these details give us a glimpse of the Philippines long before Magellan.

MANILA, Jan 24 (Reuters) - The U.S. military's Typhon launchers which can fire multi-purpose missiles up to thousands of kilometres will stay in the Philippines for the time being, the national ...

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.